Skip to main content
Oncotarget logoLink to Oncotarget
. 2022 Dec 17;13:1322. doi: 10.18632/oncotarget.28325

Retraction: Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity

Yueqiang Jiang 1,*, Yanling Ma 2,*, RuiChao Li 1,, JianHai Sun 2,
PMCID: PMC9760265  PMID: 36528880

This article has been retracted: During its investigation, Oncotarget requested the original data for this paper from the authors. The authors state: “After investigation, we determined that some original data were lost and we cannot repeat the results, making data interpretation difficult and conclusion unreliable.” All authors have therefore agreed to the retraction of this paper from Oncotarget.

Original article: Oncotarget. 2018; 9:11989–11998. 11989-11998. https://doi.org/10.18632/oncotarget.22857


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES